An estimated five to ten percent of blindness worldwide is due to the rare inflammatory eye disease uveitis. Intermediate uveitis is often associated with a chronic course of the disease and the need ...
August 29, 2012 — The US Food and Drug Administration (FDA) has granted orphan drug status to gevokizumab (Xoma 052, Xoma Corp), a monoclonal antibody that binds strongly to interleukin 1β (IL-1β), ...
An international coalition of eye researchers used machine learning to develop classification criteria for 25 of the most common types of uveitis, a collection of over 30 diseases characterized by ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Hosted on MSN
Early detection is key to improving treatment of uveitis, a global leading cause of vision loss
New treatment guidance has been developed to help doctors tackle uveitis—one of the leading causes of vision loss. The new clinical guidance, by a team at the University of Bristol, aims to help ...
Classification criteria developed using machine learning will allow doctors to conduct disease-specific research about this collection of inflammatory eye diseases. The Standardization of Uveitis ...
An investigational Janus kinase 1 (JAK1) preferential inhibitor reduced the risk of treatment failure among patients with active noninfectious uveitis, the phase II randomized HUMBOLDT trial showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results